Skip to main content

Peer Review reports

From: The effect of the dual Src/Abl kinase inhibitor AZD0530 on Philadelphia positive leukaemia cell lines

Original Submission
5 Aug 2008 Submitted Original manuscript
29 Aug 2008 Reviewed Reviewer Report - Frank Boschelli
27 Oct 2008 Reviewed Reviewer Report - Sufi Thomas
3 Nov 2008 Reviewed Reviewer Report - Ellen Weisberg
2 Jan 2009 Author responded Author comments - Martin Ruthardt
Resubmission - Version 2
2 Jan 2009 Submitted Manuscript version 2
Resubmission - Version 3
Submitted Manuscript version 3
22 Jan 2009 Reviewed Reviewer Report - Sufi Thomas
26 Jan 2009 Reviewed Reviewer Report - Ellen Weisberg
29 Jan 2009 Author responded Author comments - Martin Ruthardt
Resubmission - Version 4
29 Jan 2009 Submitted Manuscript version 4
7 Feb 2009 Author responded Author comments - Martin Ruthardt
Resubmission - Version 5
7 Feb 2009 Submitted Manuscript version 5
Resubmission - Version 6
Submitted Manuscript version 6
12 Feb 2009 Author responded Author comments - Martin Ruthardt
Resubmission - Version 7
12 Feb 2009 Submitted Manuscript version 7
Publishing
13 Feb 2009 Editorially accepted
13 Feb 2009 Article published 10.1186/1471-2407-9-53

You can find further information about peer review here.

Back to article page